Form 4: Inari Medical Director William Hoffman Reports Beneficial Ownership Changes Following Merger with Stryker

Director William Hoffman reports changes in beneficial ownership of Inari Medical stock following the merger with Stryker Corporation, where each share was converted to $80.00 in cash.

Summary

• On February 19, 2025, Inari Medical, Inc. merged with Eagle 1 Merger Sub, Inc., a subsidiary of Stryker Corporation, with Inari Medical surviving as a wholly-owned subsidiary of Stryker.
• As a result of the merger, each outstanding share of Inari Medical common stock was converted into the right to receive $80.00 in cash.
• William Hoffman, a director of Inari Medical, reported the cancellation of 238,987 shares of common stock, including 15,053 restricted stock units (RSUs).
• The RSUs were also converted into the right to receive cash equal to the number of shares underlying the RSUs multiplied by the merger consideration of $80.00 per share.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as the merger provides a clear exit for shareholders at a defined price. The filing itself is a standard procedure following such a transaction.

Positives

• The merger provides a clear exit strategy for shareholders at a defined price of $80.00 per share.
• Director William Hoffman received cash for his shares and RSUs as part of the merger agreement.

Future Outlook

The document does not contain forward-looking statements beyond the completion of the merger.

Industry Context

The acquisition of Inari Medical by Stryker reflects a trend of consolidation in the medical device industry, where larger companies acquire smaller, innovative firms to expand their product portfolios and market reach.

Comparison to Industry Standards

• Mergers and acquisitions in the medical device industry often involve a premium paid over the target company's pre-acquisition stock price.
• The $80.00 per share merger consideration should be compared to Inari Medical's trading price prior to the announcement to assess the premium received by shareholders.
• Comparable transactions in the medical device space can be analyzed to determine if the valuation was in line with industry standards.

Stakeholder Impact

• Shareholders received $80.00 per share as a result of the merger.
• Employees of Inari Medical may experience changes as the company integrates into Stryker Corporation.

Key Dates

Keywords

Merger, Inari Medical, Stryker, Beneficial Ownership, Form 4, Hoffman, NARI, RSUs